EP2309982 - CONTROLLED RELEASE COPOLYMER FORMULATION WITH IMPROVED RELEASE KINETICS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 12.05.2017 Database last updated on 06.07.2024 | |
Former | Examination is in progress Status updated on 26.01.2017 | Most recent event Tooltip | 12.05.2017 | Application deemed to be withdrawn | published on 14.06.2017 [2017/24] | Applicant(s) | For all designated states Tolmar Therapeutics, Inc. 701 Centre Avenue Fort Collins, CO 80526 / US | [2011/16] | Inventor(s) | 01 /
NORTON, Richard, L. 199 Camino Real Ft. Collins CO 80524 / US | 02 /
DADEY, Eric 3320 Lancashire Road Furlong PA 18925 / US | [2011/16] | Representative(s) | Peters, Hajo, et al ZACCO GmbH Bayerstrasse 83 80335 München / DE | [N/P] |
Former [2011/16] | Peters, Hajo, et al ZACCO GmbH Bayerstrasse 83 80335 München / DE | ||
Former [2011/16] | Peters, Hajo, et al Albihns.Zacco GmbH Bayerstraße 83 DE-80335 München / DE | Application number, filing date | 09758744.8 | 03.06.2009 | [2011/16] | WO2009US03362 | Priority number, date | US20080058477P | 03.06.2008 Original published format: US 58477 P | [2011/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2009148580 | Date: | 10.12.2009 | Language: | EN | [2009/50] | Type: | A2 Application without search report | No.: | EP2309982 | Date: | 20.04.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.12.2009 takes the place of the publication of the European patent application. | [2011/16] | Search report(s) | International search report - published on: | EP | 25.11.2010 | Classification | IPC: | A61K9/06, A61K47/34, A61K38/09, A61K38/31, A61K31/519, A61K47/22, A61K47/18, A61K47/20, A61K47/10 | [2011/16] | CPC: |
A61K38/09 (EP,US);
A61K31/519 (EP,US);
A61K38/31 (EP,US);
A61K47/34 (EP,US);
A61K9/0024 (EP,US);
A61P23/00 (EP);
A61P29/00 (EP);
A61P5/02 (EP);
A61K47/10 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2011/16] | Title | German: | COPOLYMER-FORMULIERUNG MIT KONTROLLIERTER FREISETZUNG UND VERBESSERTER FREISETZUNGSKINETIK | [2011/16] | English: | CONTROLLED RELEASE COPOLYMER FORMULATION WITH IMPROVED RELEASE KINETICS | [2011/16] | French: | FORMULATION COPOLYMÉRIQUE À LIBÉRATION CONTRÔLÉE PRÉSENTANT UNE CINÉTIQUE DE LIBÉRATION AMÉLIORÉE | [2011/16] | Entry into regional phase | 20.12.2010 | National basic fee paid | 20.12.2010 | Designation fee(s) paid | 20.12.2010 | Examination fee paid | Examination procedure | 20.12.2010 | Examination requested [2011/16] | 06.04.2011 | Amendment by applicant (claims and/or description) | 12.11.2013 | Despatch of a communication from the examining division (Time limit: M06) | 09.04.2014 | Reply to a communication from the examining division | 03.01.2017 | Application deemed to be withdrawn, date of legal effect [2017/24] | 27.01.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2017/24] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 12.11.2013 | Fees paid | Renewal fee | 13.06.2011 | Renewal fee patent year 03 | 14.06.2012 | Renewal fee patent year 04 | 10.06.2013 | Renewal fee patent year 05 | 31.03.2014 | Renewal fee patent year 06 | 10.06.2015 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 30.06.2016 | 08   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]WO2008045516 (QLT USA INC [US], et al) [X] 1-11,13-33,35,36,44 * page 4, line 10 - page 5, line 16 * * examples 1-4 * * tables 1,3,4 * * figures 1-3 * * claims 1,4-10,24-41 * [I] 12,34,37-43; | [XI]WO2006065951 (QLT USA INC [US], et al) [X] 1-9,11,13-24,26,27,29-33,35,38-44 * page 5, line 25 - page 8, line 20 * * page 10, line 13 - line 22 * * page 21, line 31 - line 33 * * page 28, line 19 - line 30 * * page 29, line 12 - line 14 * * page 30, line 1 - line 27 * * examples 1-8 * * figures 1,3,5 * * table 9.2 * * claims 1-31 * [I] 10,12,25,28,37; | [XI]WO0238185 (ATRIX LAB INC [US], et al) [X] 1,2,5,7,8,13-15,17,18,20-23,26,29-33,37-44 * page 3, line 14 - page 4, line 21 * * page 8, line 5 - line 15 * * page 12, line 21 - page 13, line 11 * * examples 1-6 * * claims 1-65 * [I] 3,4,6,9-12,19,25,27,28; | [XI]WO0249573 (BHAGWATWAR HARSHAL PRABHAKAR [IN], et al) [X] 1-5,7,8,11-18,20-24,26-37,44 * page 1, line 6 - line 12 * * page 5, line 18 - line 29 * * examples 1-32 * * claims 1-68 * [I] 6,9,10,19,25,38-43; | [XP]WO2008100532 (QLT USA INC [US], et al) [XP] 1-9,11,13-24,26,27,29-44 * page 3, line 20 - page 4, line 18 * * examples 1,2a-f * * tables 1-6 * * claims 1-40 *; | [XP]US2008194663 (DUNN RICHARD L [US]) [XP] 1-6,11,13-19,21-24,26,27,29-34,38-44 * paragraph [0002] * * paragraph [0008] - paragraph [0014] * * examples 1-7 * * claims 1-15,47-55 * |